Global Premises

On May 1, 2009, there had been a recall of fourteen Hydroxycut diet-aid products springing from a number of reports that folks using the products were developing significant liver problems and other health concerns. Less than 7 days later, on May 4, the first Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Case alleges company laxity in informing the public about potential risks of the products. Naturally, it’s too soon to grasp the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.

A class action legal action is filed by a bunch of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less dear, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there is a settlement. At that time, the attorney who handled the suit will take his fees from the compensation that got given and then assign the remaining funds to the litigants in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action legal actions became so popular.

The initial class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall occurred in the United States where twenty-three cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive seventeen reports concerning people who sustained respiratory, neurological, cardio, and gut issues as a result of Canadians using the products.

The Hydroxycut Liver Damage Suits alleges the company sold the products without correctly informing the products without properly informing the public of the health risks that they could exposing buyers to. The complaint states that the company failed to publish the data on the product labels saying that users could run the chance of liver and kidney damage as well as gut, cardio, respiratory, and neurological issues. The suit goes on to claim this was a blatant omission on the part of the company which deliberately misled buyers concerning the security of the products.